SciBase Holding AB (publ) (SCIB.ST)
SEK 0.37
(-6.03%)
SEK 0.37
(-6.03%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 11.91 Million SEK | 63.45% |
| 2022 | 7.29 Million SEK | 7.24% |
| 2021 | 6.8 Million SEK | -1.62% |
| 2020 | 6.91 Million SEK | 38.16% |
| 2019 | 5 Million SEK | 29.01% |
| 2018 | 3.87 Million SEK | -14.09% |
| 2017 | 4.51 Million SEK | 11.79% |
| 2016 | 4.03 Million SEK | -24.76% |
| 2015 | 5.36 Million SEK | 467.94% |
| 2014 | 945 Thousand SEK | -40.75% |
| 2013 | 1.59 Million SEK | 108.25% |
| 2012 | 765.91 Thousand SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 10.71 Million SEK | -6.31% |
| 2024 Q1 | 11.43 Million SEK | -4.09% |
| 2023 Q4 | 11.91 Million SEK | 18.81% |
| 2023 Q1 | 7.44 Million SEK | 2.08% |
| 2023 Q3 | 10.03 Million SEK | -2.85% |
| 2023 FY | 11.91 Million SEK | 63.45% |
| 2023 Q2 | 10.32 Million SEK | 38.72% |
| 2022 Q1 | 6.67 Million SEK | -1.85% |
| 2022 Q3 | 5.97 Million SEK | -15.57% |
| 2022 FY | 7.29 Million SEK | 7.24% |
| 2022 Q4 | 7.29 Million SEK | 21.96% |
| 2022 Q2 | 7.08 Million SEK | 6.11% |
| 2021 Q2 | 7.54 Million SEK | 4.1% |
| 2021 Q4 | 6.8 Million SEK | -14.14% |
| 2021 Q3 | 7.92 Million SEK | 5.0% |
| 2021 Q1 | 7.24 Million SEK | 4.83% |
| 2021 FY | 6.8 Million SEK | -1.62% |
| 2020 Q3 | 6.07 Million SEK | 12.03% |
| 2020 Q4 | 6.91 Million SEK | 13.83% |
| 2020 Q1 | 4.58 Million SEK | -8.41% |
| 2020 FY | 6.91 Million SEK | 38.16% |
| 2020 Q2 | 5.42 Million SEK | 18.29% |
| 2019 Q2 | 5.46 Million SEK | 10.6% |
| 2019 FY | 5 Million SEK | 29.01% |
| 2019 Q4 | 5 Million SEK | -11.2% |
| 2019 Q3 | 5.63 Million SEK | 3.02% |
| 2019 Q1 | 4.94 Million SEK | 27.51% |
| 2018 FY | 3.87 Million SEK | -14.09% |
| 2018 Q1 | 4.79 Million SEK | 6.11% |
| 2018 Q2 | 4.36 Million SEK | -8.85% |
| 2018 Q3 | 4.03 Million SEK | -7.67% |
| 2018 Q4 | 3.87 Million SEK | -3.8% |
| 2017 Q4 | 4.51 Million SEK | 0.11% |
| 2017 FY | 4.51 Million SEK | 11.79% |
| 2017 Q3 | 4.5 Million SEK | 9.63% |
| 2017 Q2 | 4.11 Million SEK | 26.48% |
| 2017 Q1 | 3.25 Million SEK | -19.47% |
| 2016 Q1 | 5.42 Million SEK | 1.04% |
| 2016 Q3 | 4.48 Million SEK | -9.53% |
| 2016 Q2 | 4.96 Million SEK | -8.5% |
| 2016 Q4 | 4.03 Million SEK | -10.05% |
| 2016 FY | 4.03 Million SEK | -24.76% |
| 2015 FY | 5.36 Million SEK | 467.94% |
| 2015 Q2 | 2.29 Million SEK | 114.67% |
| 2015 Q3 | 4.48 Million SEK | 95.34% |
| 2015 Q4 | 5.36 Million SEK | 19.61% |
| 2015 Q1 | 1.07 Million SEK | 13.23% |
| 2014 FY | 945 Thousand SEK | -40.75% |
| 2014 Q4 | 945 Thousand SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2013 FY | 1.59 Million SEK | 108.25% |
| 2012 FY | 765.91 Thousand SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Acarix AB (publ) | 6.83 Million SEK | -74.28% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 90.166% |
| ADDvise Group AB (publ) | 121.2 Million SEK | 90.166% |
| Arcoma AB | 28.02 Million SEK | 57.473% |
| Bactiguard Holding AB (publ) | 29.64 Million SEK | 59.796% |
| BICO Group AB (publ) | 493.1 Million SEK | 97.583% |
| Boule Diagnostics AB (publ) | 62.4 Million SEK | 80.899% |
| CellaVision AB (publ) | 126.03 Million SEK | 90.543% |
| Clinical Laserthermia Systems AB (publ) | 6.11 Million SEK | -94.914% |
| Chordate Medical Holding AB (publ) | 1.77 Million SEK | -573.04% |
| C-Rad AB (publ) | 64.09 Million SEK | 81.406% |
| Duearity AB (publ) | 4.15 Million SEK | -186.583% |
| Dignitana AB (publ) | 7.41 Million SEK | -60.785% |
| Episurf Medical AB (publ) | 3.7 Million SEK | -222.135% |
| Getinge AB (publ) | 6.41 Billion SEK | 99.814% |
| Scandinavian Real Heart AB (Publ) | -1.68 Million SEK | 808.044% |
| Iconovo AB (publ) | -4.86 Million SEK | 345.146% |
| Integrum AB (publ) | 22.36 Million SEK | 46.7% |
| Luxbright AB (publ) | 8000.00 SEK | -148887.5% |
| Mentice AB (publ) | 14.1 Million SEK | 15.492% |
| OssDsign AB (publ) | 4.3 Million SEK | -176.928% |
| Paxman AB (publ) | 19.99 Million SEK | 40.402% |
| Promimic AB (publ) | 330 Thousand SEK | -3511.818% |
| Qlife Holding AB (publ) | 7.29 Million SEK | -63.453% |
| ScandiDos AB (publ) | 22.69 Million SEK | 47.47% |
| Sectra AB (publ) | 36.59 Million SEK | 67.426% |
| Sedana Medical AB (publ) | 42.97 Million SEK | 72.265% |
| Senzime AB (publ) | 20.34 Million SEK | 41.401% |
| SpectraCure AB (publ) | 1.00 SEK | -1191899900.0% |
| Stille AB | 66.55 Million SEK | 82.091% |
| Vitrolife AB (publ) | 413 Million SEK | 97.114% |
| Xvivo Perfusion AB (publ) | 141.6 Million SEK | 91.583% |